Singapore, Aug. 31 -- Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-generation antibody-drug conjugates using its proprietary DUPA... Read More
Singapore, Aug. 31 -- Taiwan-based Formosa Pharmaceuticals has submitted a Clinical Trial Application to European regulators for a pivotal study of TSY-110, its biosimilar candidate referencing the HE... Read More
Singapore, Aug. 28 -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and res... Read More
Singapore, Aug. 28 -- AUScelerate and the Shanghai Center of Biomedicine Development have signed a Memorandum of Understanding (MoU) to build collaborative links and open-up new market opportunities f... Read More
Singapore, Aug. 28 -- DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (APIs) in Thailand. The acquisition strengthens DKSH Perfor... Read More
Singapore, Aug. 28 -- Inflammatory bowel disease (IBD) can be deceptive. Over time, this unseen inflammation can damage the intestinal lining and cause ulcers, even before symptoms become apparent. Th... Read More
Singapore, Aug. 28 -- South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced a rights offering to raise an expected aggregate amount o... Read More
Singapore, Aug. 28 -- Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mitsubishi Gas Chemical to bring a pipeline of pharmaceutical-... Read More
Singapore, Aug. 28 -- Australian oncology biotechnology company Kazia Therapeutics has reported a 100% clinical benefit rate among the first six evaluable patients treated with paxalisib in a study in... Read More
Singapore, Aug. 27 -- Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluating a novel CAR T-cell therapy in patients with relapsed o... Read More